Symbols / CJMB Stock $1.11 +11.00% Callan JMB Inc.

Industrials • Integrated Freight & Logistics • United States • NCM
CJMB (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Industrials
Industry Integrated Freight & Logistics
CEO Mr. Wayne Williams
Exch · Country NCM · United States
Market Cap 6.25M
Enterprise Value 6.10M
Income -7.97M
Sales 5.72M
FCF (ttm) -2.58M
Book/sh 0.48
Cash/sh 0.38
Employees 18
Insider 10d —
IPO Feb 05, 2025
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG —
P/S 1.09
P/B 2.32
P/C —
EV/EBITDA -0.96
EV/Sales 1.07
Quick Ratio 1.75
Current Ratio 2.16
Debt/Eq 85.36
LT Debt/Eq —
EPS (ttm) -1.82
EPS next Y —
EPS Growth —
Revenue Growth -14.10%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA -74.74%
ROE -289.61%
ROIC —
Gross Margin 36.77%
Oper. Margin -169.61%
Profit Margin -139.20%
Shs Outstand 5.63M
Shs Float 2.42M
Insider Own 62.59%
Instit Own 12.76%
Short Float 5.55%
Short Ratio 0.54
Short Interest 116.82K
52W High 5.88
vs 52W High -81.12%
52W Low 0.86
vs 52W Low 29.67%
Beta —
Impl. Vol. —
Rel Volume 0.26
Avg Volume 322.53K
Volume 85.32K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $1.00
Price $1.11
Change 11.00%
About

Callan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry in United States. It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities. The company also provides emergency preparedness services, which includes managing their building sites, medical stockpiles of equipment, and supplies and responding to state or local emergencies; perishable (non-pharma) client packaging; technical services; and advanced monitoring sentry technology. The company was founded in 2006 and is headquartered in Spring Branch, Texas.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$1.11
Latest analyst target
3. DCF / Fair value
$-8.24
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.11
Low
—
High
—
Mean
—
News
RSS: Latest CJMB news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-20 CROYLE DAVID J. Officer and Beneficial Owner of more than 10% of a Class of Security — 10,195 $1.75 $17,841
2026-03-06 CROYLE DAVID J. Officer and Beneficial Owner of more than 10% of a Class of Security — 14,805 $1.76 $26,086
2025-12-30 DIAL GERALD Director — 2,000 $1.20 $2,409
2025-12-16 WILLIAMS WAYNE D Chief Executive Officer — 5,000 $1.73 $8,650
2025-12-15 WILLIAMS WAYNE D Chief Executive Officer — 15,798 $1.70 $27,108
2025-12-11 WILLIAMS WAYNE D Chief Executive Officer — 44,545 $1.65 $73,499
2025-12-09 DUKE LIBERTY SMITH Director — 1,512 $1.52 $2,334
2025-03-27 CROYLE DAVID J. Officer and Beneficial Owner of more than 10% of a Class of Security — 25,000 $4.50 $112,500
2025-02-05 CROYLE DAVID J. Officer and Beneficial Owner of more than 10% of a Class of Security — 24,375 $4.00 $97,500
2025-02-05 WILLIAMS WAYNE D Chief Executive Officer — 63,125 $4.00 $252,500
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
5.72
-12.80%
6.56
-50.29%
13.20
-42.01%
22.77
Operating Revenue
5.72
-12.80%
6.56
-50.29%
13.20
-42.01%
22.77
Cost Of Revenue
3.62
-9.54%
4.00
-47.04%
7.55
-43.27%
13.32
Reconciled Cost Of Revenue
3.62
-9.54%
4.00
-47.04%
7.55
-43.27%
13.32
Gross Profit
2.10
-17.90%
2.56
-54.63%
5.65
-40.23%
9.45
Operating Expense
8.60
+77.70%
4.84
+40.35%
3.45
+9.29%
3.15
Selling General And Administration
8.60
+77.70%
4.84
+40.35%
3.45
+9.29%
3.15
Total Expenses
12.22
+38.21%
8.84
-19.66%
11.00
-33.21%
16.47
Operating Income
-6.49
-185.41%
-2.27
-203.30%
2.20
-65.03%
6.30
Total Operating Income As Reported
-7.03
-209.24%
-2.27
-203.30%
2.20
-65.03%
6.30
EBITDA
-7.81
-268.75%
-2.12
-191.54%
2.32
-63.66%
6.37
Normalized EBITDA
-6.90
-225.66%
-2.12
-191.54%
2.32
-63.66%
6.37
Reconciled Depreciation
0.15
+5.75%
0.14
+39.78%
0.10
+50.10%
0.07
EBIT
-7.97
-252.05%
-2.26
-202.29%
2.21
-64.90%
6.30
Total Unusual Items
-0.91
0.00
—
—
Total Unusual Items Excluding Goodwill
-0.91
0.00
—
—
Special Income Charges
-0.54
0.00
—
—
Impairment Of Capital Assets
0.54
0.00
—
—
Net Income
-7.97
-247.32%
-2.29
-205.16%
2.18
-64.94%
6.22
Pretax Income
-7.97
-251.34%
-2.27
-202.91%
2.20
-64.99%
6.30
Net Non Operating Interest Income Expense
0.01
-7.90%
0.01
+219.41%
0.00
+133.43%
-0.01
Interest Expense Non Operating
0.00
-50.20%
0.01
-33.93%
0.01
+32.90%
0.01
Net Interest Income
0.01
-7.90%
0.01
+219.41%
0.00
+133.43%
-0.01
Interest Expense
0.00
-50.20%
0.01
-33.93%
0.01
+32.90%
0.01
Interest Income Non Operating
0.01
-26.99%
0.01
+16.98%
0.01
0.00
Interest Income
0.01
-26.99%
0.01
+16.98%
0.01
0.00
Other Income Expense
-1.48
—
—
0.00
Other Non Operating Income Expenses
-0.57
—
—
0.00
Gain On Sale Of Security
-0.37
—
—
—
Tax Provision
-0.00
-111.69%
0.03
+10.29%
0.02
-69.33%
0.07
Tax Rate For Calcs
0.00
-100.00%
0.00
+2000.00%
0.00
-9.09%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-7.97
-247.32%
-2.29
-205.16%
2.18
-64.94%
6.22
Net Income From Continuing Operation Net Minority Interest
-7.97
-247.32%
-2.29
-205.16%
2.18
-64.94%
6.22
Net Income From Continuing And Discontinued Operation
-7.97
-247.32%
-2.29
-205.16%
2.18
-64.94%
6.22
Net Income Continuous Operations
-7.97
-247.32%
-2.29
-205.16%
2.18
-64.94%
6.22
Normalized Income
-7.05
-207.50%
-2.29
-205.16%
2.18
-64.94%
6.22
Net Income Common Stockholders
-7.97
-247.32%
-2.29
-205.16%
2.18
-64.94%
6.22
Diluted EPS
—
-0.54
-254.30%
0.35
-76.11%
1.45
Basic EPS
—
-0.54
-205.16%
0.51
-64.94%
1.45
Basic Average Shares
—
4.28
+0.00%
4.28
+0.00%
4.28
Diluted Average Shares
—
4.28
-31.85%
6.28
+46.73%
4.28
Diluted NI Availto Com Stockholders
-7.97
-247.32%
-2.29
-205.16%
2.18
-64.94%
6.22
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
5.78
+13.64%
5.08
-47.63%
9.71
-36.36%
15.25
Current Assets
3.06
-7.85%
3.32
-60.73%
8.45
-41.18%
14.37
Cash Cash Equivalents And Short Term Investments
2.13
+1.56%
2.10
-59.31%
5.16
-16.76%
6.19
Cash And Cash Equivalents
2.13
+1.56%
2.10
-59.31%
5.16
-16.76%
6.19
Cash Financial
—
2.10
-59.31%
5.16
-16.76%
6.19
Receivables
0.34
-47.03%
0.65
-77.82%
2.92
-62.87%
7.87
Accounts Receivable
0.34
-44.90%
0.62
-78.51%
2.90
-63.07%
7.85
Gross Accounts Receivable
0.40
-41.05%
0.69
-79.04%
3.28
-58.78%
7.95
Allowance For Doubtful Accounts Receivable
-0.06
+3.63%
-0.06
+83.10%
-0.38
-272.38%
-0.10
Taxes Receivable
0.00
-100.00%
0.01
0.00
—
Loans Receivable
0.00
-100.00%
0.02
-15.02%
0.02
+32.09%
0.02
Inventory
0.24
+53.63%
0.16
+38.02%
0.11
+44.43%
0.08
Raw Materials
—
—
0.11
+44.43%
0.08
Current Deferred Assets
0.00
-100.00%
0.14
+444.10%
0.03
0.00
Other Current Assets
0.34
+22.38%
0.28
+18.18%
0.24
+2.81%
0.23
Total Non Current Assets
2.72
+54.09%
1.76
+40.72%
1.25
+42.15%
0.88
Net PPE
2.72
+54.41%
1.76
+40.84%
1.25
+42.33%
0.88
Gross PPE
4.02
+69.73%
2.37
+38.05%
1.72
+38.35%
1.24
Accumulated Depreciation
-1.30
-114.02%
-0.61
-30.56%
-0.47
-28.72%
-0.36
Machinery Furniture Equipment
2.00
+44.59%
1.38
+3.36%
1.34
+41.01%
0.95
Other Properties
2.02
+105.03%
0.99
+161.13%
0.38
+29.68%
0.29
Non Current Prepaid Assets
0.00
-100.00%
0.00
+0.00%
0.00
+0.00%
0.00
Total Liabilities Net Minority Interest
3.45
+80.58%
1.91
+109.74%
0.91
-26.56%
1.24
Current Liabilities
1.41
+10.90%
1.27
+65.56%
0.77
-30.67%
1.11
Payables And Accrued Expenses
1.07
+32.00%
0.81
+68.57%
0.48
-37.88%
0.78
Payables
0.59
+48.76%
0.39
-18.30%
0.48
-37.88%
0.78
Accounts Payable
0.56
+51.75%
0.37
-10.68%
0.42
-37.68%
0.67
Current Accrued Expenses
0.49
+16.24%
0.42
—
—
Total Tax Payable
0.02
+0.37%
0.02
-65.67%
0.07
-39.09%
0.11
Income Tax Payable
0.02
+0.37%
0.02
-65.67%
0.07
-39.09%
0.11
Current Debt And Capital Lease Obligation
0.34
-7.54%
0.37
+36.77%
0.27
-5.01%
0.28
Current Debt
0.01
-83.45%
0.09
-25.18%
0.12
+5.07%
0.11
Other Current Borrowings
—
—
0.02
—
Current Capital Lease Obligation
0.32
+16.03%
0.28
+84.12%
0.15
-11.50%
0.17
Current Deferred Liabilities
0.00
-100.00%
0.09
+392.32%
0.02
-62.52%
0.05
Current Deferred Revenue
0.00
-100.00%
0.09
+676.83%
0.01
0.00
Total Non Current Liabilities Net Minority Interest
2.03
+220.45%
0.63
+351.67%
0.14
+8.75%
0.13
Long Term Debt And Capital Lease Obligation
1.66
+164.73%
0.63
+374.21%
0.13
+2.50%
0.13
Long Term Capital Lease Obligation
1.66
+164.73%
0.63
+374.21%
0.13
+2.50%
0.13
Non Current Deferred Liabilities
0.00
-100.00%
0.01
-18.24%
0.01
—
Non Current Deferred Revenue
—
0.00
-100.00%
0.01
—
Non Current Deferred Taxes Liabilities
0.00
-100.00%
0.01
—
—
Stockholders Equity
2.33
-26.64%
3.17
-63.92%
8.80
0.00
Common Stock Equity
2.33
-26.64%
3.17
-63.92%
8.80
-37.23%
14.01
Capital Stock
0.00
+62.00%
0.00
0.00
—
Common Stock
0.00
+62.00%
0.00
0.00
—
Preferred Stock
0.00
0.00
0.00
—
Share Issued
4.86
+13.52%
4.28
+0.00%
4.28
+0.00%
4.28
Ordinary Shares Number
4.86
+13.52%
4.28
+0.00%
4.28
+0.00%
4.28
Additional Paid In Capital
12.58
+130.29%
5.46
0.00
—
Retained Earnings
-10.26
-347.32%
-2.29
0.00
—
Total Equity Gross Minority Interest
2.33
-26.64%
3.17
-63.92%
8.80
-37.23%
14.01
Total Capitalization
2.33
-26.64%
3.17
-63.92%
8.80
-37.23%
14.01
Working Capital
1.65
-19.54%
2.04
-73.38%
7.68
-42.06%
13.26
Invested Capital
2.34
-28.15%
3.26
-63.42%
8.91
-36.90%
14.12
Total Debt
2.00
+101.33%
0.99
+148.54%
0.40
-2.65%
0.41
Capital Lease Obligations
1.99
+118.98%
0.91
+219.40%
0.28
-5.48%
0.30
Net Tangible Assets
2.33
-26.64%
3.17
-63.92%
8.80
0.00
Tangible Book Value
2.33
-26.64%
3.17
-63.92%
8.80
-37.23%
14.01
Current Deferred Taxes Liabilities
—
0.01
-5.69%
0.01
-86.27%
0.05
Current Notes Payable
—
0.00
-100.00%
0.10
-10.41%
0.11
Derivative Product Liabilities
0.37
0.00
—
—
Limited Partnership Capital
—
—
8.80
-37.23%
14.01
Line Of Credit
0.01
-83.45%
0.09
—
—
Other Equity Interest
—
—
8.80
—
Total Partnership Capital
—
—
8.80
-37.23%
14.01
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-4.55
-941.44%
0.54
-92.28%
7.00
-25.29%
9.36
Cash Flow From Continuing Operating Activities
-4.55
-941.44%
0.54
-92.28%
7.00
-25.29%
9.36
Net Income From Continuing Operations
-7.97
-247.32%
-2.29
-205.16%
2.18
-64.94%
6.22
Depreciation Amortization Depletion
0.15
+5.75%
0.14
+39.78%
0.10
+50.10%
0.07
Depreciation
—
0.14
+39.78%
0.10
+50.10%
0.07
Depreciation And Amortization
0.15
+5.75%
0.14
+39.78%
0.10
+50.10%
0.07
Other Non Cash Items
0.52
—
—
—
Stock Based Compensation
1.56
0.00
—
—
Provisionand Write Offof Assets
0.23
+275.72%
-0.13
-147.29%
0.28
+172.38%
0.10
Asset Impairment Charge
0.54
0.00
—
—
Operating Gains Losses
0.37
—
—
—
Gain Loss On Investment Securities
0.37
—
—
—
Change In Working Capital
0.04
-98.41%
2.82
-36.38%
4.43
+49.20%
2.97
Change In Receivables
0.06
-97.67%
2.40
-48.63%
4.67
-32.09%
6.88
Changes In Account Receivables
0.05
-97.94%
2.41
-48.49%
4.67
-32.09%
6.88
Change In Inventory
-0.08
-94.67%
-0.04
-23.60%
-0.04
-154.30%
0.06
Change In Payables And Accrued Expense
0.19
-54.96%
0.42
+241.90%
-0.29
+71.46%
-1.03
Change In Payable
0.19
-54.96%
0.42
+241.90%
-0.29
+71.46%
-1.03
Change In Account Payable
0.19
-59.27%
0.46
+283.65%
-0.25
+77.20%
-1.10
Change In Other Working Capital
-0.10
-236.98%
0.07
+408.71%
-0.02
+99.22%
-3.04
Change In Other Current Assets
-0.01
+50.41%
-0.03
-123.69%
0.12
+24.72%
0.09
Change In Other Current Liabilities
—
0.00
+100.00%
-0.00
—
Investing Cash Flow
-0.62
-1236.23%
-0.05
+90.58%
-0.49
-15.98%
-0.42
Cash Flow From Continuing Investing Activities
-0.62
-1236.23%
-0.05
+90.58%
-0.49
-15.98%
-0.42
Net PPE Purchase And Sale
-0.62
-1236.23%
-0.05
+90.58%
-0.49
-15.98%
-0.42
Purchase Of PPE
-0.62
-1236.23%
-0.05
+90.58%
-0.49
-15.98%
-0.42
Capital Expenditure
-0.62
-1236.23%
-0.05
+90.58%
-0.49
-15.98%
-0.42
Financing Cash Flow
5.20
+246.30%
-3.55
+52.92%
-7.54
-65.18%
-4.57
Cash Flow From Continuing Financing Activities
5.20
+246.30%
-3.55
+52.92%
-7.54
-65.18%
-4.57
Net Issuance Payments Of Debt
0.02
+116.11%
-0.12
+0.52%
-0.12
+32.71%
-0.17
Net Long Term Debt Issuance
0.02
+116.11%
-0.12
—
—
Net Short Term Debt Issuance
—
-0.12
+0.52%
-0.12
+32.71%
-0.17
Net Common Stock Issuance
5.04
0.00
—
—
Cash Dividends Paid
0.00
+100.00%
-3.33
+55.00%
-7.40
-66.40%
-4.45
Net Other Financing Charges
0.14
+226.27%
-0.11
-255.09%
-0.03
-158.99%
0.05
Changes In Cash
0.03
+101.07%
-3.06
-194.55%
-1.04
-123.73%
4.37
Beginning Cash Position
2.10
-59.31%
5.16
-16.76%
6.19
+240.42%
1.82
End Cash Position
2.13
+1.56%
2.10
-59.31%
5.16
-16.76%
6.19
Free Cash Flow
-5.16
-1144.87%
0.49
-92.40%
6.51
-27.24%
8.94
Interest Paid Supplemental Data
0.00
-50.20%
0.01
-33.93%
0.01
+32.90%
0.01
Change In Income Tax Payable
0.00
+100.19%
-0.04
-2.33%
-0.04
-160.56%
0.07
Change In Tax Payable
0.00
+100.19%
-0.04
-2.33%
-0.04
-160.56%
0.07
Common Stock Issuance
5.04
0.00
—
—
Issuance Of Capital Stock
5.04
0.00
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category